The genetic variants in glucocerebrosidase (GBA) gene have been previously examined as potential susceptibility factors for Parkinson's disease (PD). Although of great interest, possible role of GBA gene in PD has not been well investigated in eastern Chinese population. To explore this association, we conducted a genetic screen of three common GBA variants (p.L444P, p.N370S, and p.R120W) in a casecontrol cohort comprised of 638 subjects of Chinese ethnicity. In order to provide a more precise estimate of this association, a meta-analysis was performed. We found that the GBA p.L444P allele was significantly more frequent (P = 0.001) in the PD patients (6/195 = 3.08%) than in the controls (0/443). The p.L444P mutation, but not p.N370S and p.R120W, was found to be associated with PD. Combined analysis including all previously published ancestral Chinese data yielded a highly significant association between the GBA gene and an increased risk for PD (OR = 8.13, 95% CI, 4.43-14.92, P < 0.00001). Our study suggests that the GBA gene may be a susceptibility gene for PD in the Chinese population. Efforts to elucidate in detail this interesting and biologically plausible genetic association are warranted.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4077/CJP.2011.AMM076 | DOI Listing |
Microrna
February 2025
Department of Medical Biology, Medical Faculty, Erciyes University, 38030 Kayseri, Turkey.
Background: Gaucher disease (GD) occurs due to a mutation in the glucosylcerami-dase (GBA) gene and is a common lysosomal storage disease. It is well known that there is a strong association between the abnormal expression of miRNAs and various diseases including cancer. These abnormally expressed miRNAs can be used as biomarkers.
View Article and Find Full Text PDFInt J Biol Macromol
February 2025
College of Animal Science & Technology, Gansu Agricultural University, No. 1 Yingmen Village, Anning District, Lanzhou 730070, Gansu Province, China.
As a pivotal regulatory molecule, long non-coding RNA (lncRNA) can coordinate the network regulation of transcription and post-transcriptional processes. However, little is known about their cis-regulatory contributions in gene expression of crustaceans under alkalinity stress. In this study, the purpose was to explore the potential role of lncRNA in gill of Pacific white shrimp (Litopenaeus vannamei) under different alkalinity stress (C: 50 mg/L and T: 350 mg/L).
View Article and Find Full Text PDFAm J Manag Care
February 2025
Division of Cancer Pharmacology & Pharmacogenomics, Atrium Health Levine Cancer Institute, 1021 Morehead Medical Dr, Charlotte, NC 28204. Email:
Objectives: To evaluate medical policy determinations for pharmacogenetic (PGx) testing for 65 clinically relevant drug-gene pairs and evidence cited to support determinations across major US health plans and laboratory benefit managers (LBMs).
Study Design: Landscape analysis of available PGx medical policies to determine coverage status of certain drug-gene pairs.
Methods: PGx medical policies as of February 1, 2024, were ascertained through Policy Reporter for top national insurers, LBMs, and the Palmetto GBA Molecular Diagnostic Services (MolDX) Program, which determines whether a molecular diagnostic test is covered by Medicare.
J Parkinsons Dis
November 2024
Departments of Neurology, Hadassah Medical Center and the Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Background: Compensatory mechanisms in Parkinson's disease (PD) are thought to explain the temporal delay between the beginning of the neurodegenerative process and the appearance of clinical signs. The enhanced structural integrity of the corticospinal tract was previously suggested as one of these mechanisms.
Objective: To understand the relations between corticospinal tract integrity and the anatomical, clinical, electrophysiological, and genetic PD characteristics.
J Parkinsons Dis
November 2024
The Laboratory of Biomarkers and Genomics of Neurodegeneration, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Background: The adaptive immune response has a role in Parkinson's disease (PD). Patients with or mutations often exhibit distinct clinical characteristics.
Objective: To evaluate the involvement of adaptive immune response genes in three PD groups: -PD, -PD, and non-carrier (NC)-PD.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!